The FDA has approved mFlusiva, the first mRNA flu vaccine, for adults ages 50 to 64, but the CDC has not added it to its recommended list amid legal uncertainties and disruptions to the federal ...
The Food and Drug Administration recently approved a new flu vaccine that tested well in older adults. But the federal agency ...
According to the Atlanta-based Centers for Disease Control and Prevention, the type of flu vaccine and number of doses needed can vary based on a person’s age, previous vaccination history and the ...
The CDC has not recommended mFlusiva, a new FDA-approved flu vaccine that tested well in older adults, AP reports.
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The FDA has approved the first mRNA flu vaccine, a landmark decision following earlier ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
An mRNA flu vaccine that updates close to season has finally been approved. Its speed means nothing until officials move a decades-old strain deadline ...
Key Takeaway: The FDA’s approval of mFLUSIVA may indicate increased commercial and strategic value of mRNA vaccine patents. On August 5, 2026, Moderna announced that the U.S. Food and Drug ...
The Food and Drug Administration has approved the first messenger RNA-based vaccine for seasonal flu, after rejecting it earlier this year. Moderna’s new seasonal flu vaccine using mRNA technology for ...
WASHINGTON (AP) — The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic, ...
For some older adults, the flu vaccine could look a little different this year. In August, the U.S. Food and Drug ...
The FDA-approved Moderna mRNA flu vaccine offers better protection against influenza A but may cause mild side effects; ...